Find Academic Supervisors

• Thrombosis
• Hematology
• Immunology
• +3 more

Dr. Jose Perdomo is a Research Fellow at the Central Clinical School, Sydney Medical School, within the Faculty of Medicine and Health at the University of Sydney. He is based at the Charles Perkins Centre, where his research focuses on endothelial damage, immune complex-driven thrombosis, and platelet formation mechanisms. His work employs techniques such as flow cytometry, microfluidics, and intravital microscopy. Dr. Perdomo holds a PhD from the University of Sydney’s School of Molecular and Microbial Biosciences and received a Vice-Chancellor’s Fellowship. His research has led to two international patents and recognition, including 1st prize in the 2020 China Shenzhen Innovation Competition. His studies explore targeted inhibitors to prevent immune complex formation and thrombosis, with applications in cardiovascular health. His research interests include the interplay between white blood cells, endothelial cells, and platelets, with a focus on desialylation, apoptosis, and NETosis in immune thrombocytopenia. He has contributed to understanding vaccine-induced immune thrombocytopenia and thrombotic complications post-myocardial infarction. His findings have been featured in Nature Communications , Blood Advances , and other high-impact journals. Awards: 1st prize in China Shenzhen Innovation Competition (2020). Labs/Teams: Charles Perkins Centre, University of Sydney. Grants: Vice-Chancellor’s Fellowship (University of Sydney). Media Contributions: Insights into AstraZeneca vaccine-related blood clots featured in The Guardian , SMH , and ABC News.

Jeffrey T. JensenView profile

Professor

• Contraception
• Reproductive Health
• Translational Research
• +2 more

Jeffrey T. Jensen, M.D., M.P.H., is the Leon Speroff Professor and Vice Chair for Research in the Department of Obstetrics and Gynecology at Oregon Health & Science University (OHSU). He holds joint appointments as Professor of Public Health and Preventive Medicine and serves as a Core Scientist at the Oregon National Primate Research Center (ONPRC). Dr. Jensen completed his medical degree at Emory University, a Master of Public Health at the University of Washington, and residency training at OHSU. Research Focus: Dr. Jensen leads translational and clinical research programs focused on contraceptive innovation. His work emphasizes nonhuman primate models to develop: Novel contraceptive agents targeting oocyte-specific pathways Non-surgical permanent contraception methods Optimized emergency contraception for diverse populations He directs OHSU's Women’s Health Research Unit and the Gates Foundation-funded Oregon Permanent Contraception Research Center (OPERM). Recent Publications: His 15 most recent articles (2023-2025) demonstrate concentrated expertise in: Advanced hormonal contraceptive formulations (IUDs, vaginal rings, oral agents) Weight-adjusted dosing strategies for emergency contraception Biomarker validation for contraceptive efficacy monitoring Real-world assessment of bleeding pattern management Leadership & Collaboration: Dr. Jensen is Principal Investigator of the NICHD Contraception Clinical Trials Network and collaborates with global health organizations (CONRAD, FHI360, Population Council). He serves as Deputy Editor for the journal Contraception and consults for multiple pharmaceutical companies on product development.

Adam C SteinView profile

Associate Professor

• Gastroenterology
• Hepatology
• Inflammatory Bowel Disease
• +5 more

Adam C Stein is an Associate Professor in the Department of Medicine at Northwestern University's Feinberg School of Medicine, specializing in gastrointestinal disorders of the small bowel. He provides clinical care at Northwestern Memorial Hospital and Ann & Robert H. Lurie Children's Hospital of Chicago, with expertise in Crohn's disease, celiac disease, intestinal failure, and malnutrition management. Education: MD from University of Illinois, Chicago (2007) Residency in Internal Medicine at University of Chicago (2010) Fellowship in Gastroenterology at University of Chicago (2013) Fellowship in Nutrition at University of Chicago (2014) Dr. Stein's research focuses on small bowel pathologies including obscure gastrointestinal bleeding, cystic fibrosis-related GI complications, and advanced endoscopic techniques like video capsule endoscopy and double balloon enteroscopy. His clinical work emphasizes nutritional support through parenteral nutrition and tube feeding for complex malabsorption syndromes. Recent publications (2022-2024) demonstrate concentrated research on gastrointestinal manifestations in rare diseases (nephropathic cystinosis) and cystic fibrosis, with particular attention to nutritional management barriers and drug safety profiles in inflammatory bowel disease therapies. No scientific awards are listed in the current profile. Information regarding student advising and research grants is not specified in available materials, though Dr. Stein maintains active industry collaborations through consulting roles with AbbVie, Amgen, and Takeda Pharmaceuticals. As a member of the Division of Gastroenterology and Hepatology, Dr. Stein collaborates with multidisciplinary teams across Northwestern Medicine's academic hospitals, contributing to clinical committees including the ACG Training Committee (2017-2023) and editorial boards such as Current Gastroenterology Reports (2019-2023).

Michael KrisingerView profile

Academic

• Biochemistry
• Molecular Biology
• Coagulation
• +3 more

Michael Krisinger is an Associate Professor of Teaching in the Department of Biochemistry & Molecular Biology at the University of British Columbia . He began his teaching career in 2010, transitioning to full-time in 2013. He lectures Biochemistry 202 (Introductory Medical Biochemistry) and Biochemistry 303 (Molecular Biochemistry) while serving as a tutor in the Faculty of Medicine's Case Based Learning program. Krisinger co-developed the department's two-course summer program for international students and mentors postdoctoral fellows in teaching. He also manages the department's CANVAS digital learning platform. Krisinger's research focuses on the molecular mechanisms of coagulation and complement system regulation , particularly their evolutionary relationship and functional interplay. His work has explored thrombin's role in complement activation, polyphosphate-mediated complement suppression, and nanoparticle surface interactions with proteolytic cascades. He previously co-supervised graduate students at UBC's Centre for Blood Research before prioritizing education. Publications highlight his expertise in protease-substrate dynamics , lipoprotein-phospholipid interactions , and hemostasis-immunity crosstalk . He remains engaged in public science through community environmental initiatives and local outreach activities.

• Maternal-Fetal Medicine
• Cardiovascular Disease in Pregnancy
• Hypertension in Pregnancy
• +3 more

Dr. Annalies Denoble is an Assistant Professor of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine. She specializes in maternal-fetal medicine, focusing on high-risk pregnancies, particularly those complicated by cardiovascular disease. Her research addresses gaps in understanding maternal heart disease, hypertension, and vaccine safety during pregnancy. Education: MD and MSc in Clinical Research, University of Michigan Medical School (2014) Bachelor of Arts in French Studies, Duke University (2008) Research Interests: Her work centers on cardiovascular complications in pregnancy, including hypertension, heart failure, and congenital heart disease. She collaborates with Yale's multi-disciplinary Pregnancy Heart Team to optimize care for patients with cardiac conditions. Her studies also investigate vaccine safety, preeclampsia, and maternal mortality reduction strategies. Recent Research Trends: Her publications highlight late-onset postpartum hypertension, vaccine safety in pregnancy, and hypertension progression during and after pregnancy. She emphasizes extending postpartum care and improving risk prediction models for adverse cardiac events. Awards: Recognized as a 'Top Doctor' in Yale Ob/Gyn Physicians for 2025. Collaborations & Clinics: Dr. Denoble works with the Pregnancy Heart Team and Yale Medicine's Maternal-Fetal Medicine unit. She sees patients at locations in New Haven, New London, and Waterbury, CT.

Scott L. DiamondView profile

Professor

• Mechanobiology
• Thrombolysis
• Coagulation
• +10 more

Scott L. Diamond is the Arthur E. Humphrey Professor of Chemical and Biomolecular Engineering and Bioengineering at the University of Pennsylvania's School of Engineering and Applied Sciences. He serves as Director of the Penn Center for Molecular Discovery, Director of the Penn Biotechnology Masters Program (one of the largest in the country with over 130 students), and Associate Director of the Institute for Medicine and Engineering (IME). His laboratory is located in the Roy and Diana Vagelos Laboratories at 3340 Smith Walk, 1020 Vagelos Research Laboratories, Philadelphia, PA. Diamond's research spans multiple interconnected fields in blood biology and biotechnology. His work focuses on mechanobiology, thrombolysis, coagulation, bioadhesion, gene therapy, drug/device development, proteomics, drug discovery, systems biology, and microfluidics. His laboratory has developed numerous specialized microfluidic devices for studying blood clotting under various flow conditions, including 8-channel devices for high-throughput clotting assays, side-view devices for clot structure analysis, stenosis devices for high shear clotting assays, and impingement-post devices for studying von Willebrand factor fibers. Diamond's research group has pioneered approaches to model and predict blood function using systems biology principles. His team has developed computational models that integrate reaction-transport phenomena with platelet signaling networks to predict thrombus formation under flow. These models have enabled the development of 'virtual blood' computer simulations that can predict the effectiveness of anticoagulation drugs for individual patients, contributing significantly to personalized medicine approaches in hemostasis and thrombosis. His extensive publication record demonstrates a consistent focus on understanding the fundamental mechanisms of blood clot formation and dissolution. Recent work has emphasized microfluidic approaches for point-of-care diagnostics, patient-specific modeling of platelet function, and the development of novel therapeutic strategies for thrombotic disorders. His research bridges engineering principles with clinical hematology to address significant challenges in cardiovascular medicine. NSF National Young Investigator Award NIH FIRST Award American Heart Association Established Investigator Award AIChE Allan P. Colburn Award George Heilmeier Excellence in Research Award Elected Fellow of the Biomedical Engineering Society (BMES) Diamond has secured significant research funding, including a $2.8 million NIH grant for 'Blood Systems Biology' and a $9.5 million NIH grant for the Penn Center for Molecular Discovery. His laboratory has developed numerous microfluidic devices for blood analysis and has collaborated extensively with clinicians and industry partners. Diamond has served on advisory committees for NSF, NIH, AHA, and NASA, and has consulted extensively for industry and government. With over 180 publications and patents, his work has significantly advanced the understanding of blood clotting mechanisms and the development of diagnostic and therapeutic approaches for thrombotic disorders.

Mehmet KarahanView profile

Associate Professor

• Cardiovascular Surgery
• Cardiac Surgery
• Mechanical Circulatory Support
• +4 more

Mehmet Karahan is an Associate Professor in the Department of Cardiovascular Surgery at Gaziantep University Faculty of Medicine. He specializes in cardiovascular surgery with a focus on mechanical circulatory support, left ventricular assist devices (LVAD), heart transplantation, and endovascular procedures. His clinical and research work centers on innovative approaches to treating complex cardiac conditions. His educational background includes: Medical License (English Program): Hacettepe University Faculty of Medicine (2004-2011), Turkey Specialization in Cardiovascular Surgery: Health Sciences University, Ankara High Specialized Health Application and Research Center (2012-2017), Turkey Dr. Karahan's research interests span multiple areas within cardiovascular medicine. He has made significant contributions to the field of mechanical circulatory support, particularly focusing on left ventricular assist devices (LVAD) and their applications in both adult and pediatric patients. His work explores minimally invasive approaches to LVAD implantation, management of complications, and integration with other cardiac procedures. Additionally, he has expertise in endovascular aortic repair techniques, including complex cases involving traumatic injuries and challenging anatomies. His research also extends to heart transplantation, anticoagulation management, and thrombophilia in vascular disease. Analysis of Dr. Karahan's recent publications reveals a strong focus on advancing mechanical circulatory support technologies, particularly LVAD systems. His work addresses critical challenges in the field including pediatric applications, minimally invasive techniques, management of complications like pump thrombosis, and integration with other cardiac procedures. He has also made significant contributions to endovascular aortic repair, developing innovative techniques for complex cases. His research demonstrates a multidisciplinary approach that bridges surgical innovation with patient-centered outcomes. Dr. Karahan is an active member of several professional organizations: European Association for Cardio-Thoracic Surgery (EACTS) - Member since 2024 International Society for Heart and Lung Transplantation (ISHLT) - Member since 2023 National Association of Vascular and Endovascular Surgery - Member since 2020 Turkish Cardiovascular Surgery Association - Member since 2014 He has served as an editor for The Turkish Journal of Thoracic and Cardiovascular Surgery (2025). His clinical work involves complex cardiovascular procedures, with a particular emphasis on innovative approaches to mechanical circulatory support and endovascular interventions. Dr. Karahan has presented his research at numerous national and international conferences, contributing to the advancement of cardiovascular surgical techniques. His professional experience includes positions at Gaziantep University, Ankara Bilkent City Hospital, and Turkey High Specialization Hospital. He has also gained international experience through observer positions at Paracelsus Medical University-Nuremberg Clinic, Hannover Medical School, University of Geneva, and Harvard University.

Carolyn Zahler-MillerView profile

Associate Professor

• Abnormal Uterine Bleeding
• PCOS
• Menopausal Medicine
• +4 more

Carolyn Zahler-Miller serves as Associate Professor and Assistant Dean for Clinical Integration at Augusta University's Medical College of Georgia, Department of Obstetrics and Gynecology. She directs the Ob/Gyn medical student clerkship and provides clinical care at downtown Augusta and Grovetown sites, specializing in abnormal uterine bleeding, PCOS, menopausal medicine, and breastfeeding optimization. Her educational background includes: MD, University of Florida, 2014 BS in Chemistry, University of Florida, 2010 Dr. Zahler-Miller's research focuses on women's health across the lifespan, with expertise in abnormal uterine bleeding, PCOS, menopausal disorders, breastfeeding medicine, HPV vaccination, and gestational diabetes. Her work integrates clinical practice with educational innovation to develop evidence-based interventions for patient care and physician training. Recent publications (2023-2025) demonstrate her commitment to translational research, spanning mobile health applications for breastfeeding support, RSV prevention in newborns, surgical decision-making in benign gynecology, menopausal sexual health therapies, and cost-effective surgical training models. These works highlight her dual focus on clinical outcomes and medical education advancement. Notable honors include: AU/MCG Woman Who Inspires (2023) Fellow of the American College of Obstetricians and Gynecologists (2021) As an educator, Dr. Zahler-Miller teaches 12+ medical student courses, chairs the Ob/Gyn Student Advising Committee, and serves on departmental and college committees including the Executive Committee and Curriculum Enrichment Committee. She actively shapes medical education through curriculum development, student mentorship, and clerkship leadership while maintaining clinical practice in general obstetrics and gynecology.

Anne-Mette HvasView profile

Professor

• Hematology
• Thrombosis and Hemostasis
• Platelet Function
• +7 more

Anne-Mette Hvas is Professor and Dean at the Faculty of Health, Aarhus University, Denmark, where she leads academic and administrative initiatives in health sciences. Her role places her at the forefront of institutional strategy, research development, and interdisciplinary collaboration within clinical and translational medicine. Research Interests: Her work spans hematology, coagulation, platelet biology, neonatal hemostasis, and endocrinology. She investigates thrombotic and bleeding disorders in clinical contexts such as nephrotic syndrome, pregnancy, cancer surgery, and stroke. Her research integrates physiological, pharmacological, and clinical perspectives to improve patient outcomes. The recent publications reflect a strong focus on thrombin generation, platelet reactivity, endothelial dysfunction, and red blood cell behavior in acute and chronic conditions. These studies often involve multicenter collaborations and contribute to evidence-based practices in thromboprophylaxis, surgical safety, and stroke management. Scientific Contributions: Active research in hemostasis and thrombosis across diverse patient populations Leadership in clinical studies on anticoagulation, HIPEC, and neonatal platelet function Investigations into hormonal and cardiovascular aspects of Turner syndrome Advising and Grants: While specific advisees are not listed, her leadership in multiple funded research projects suggests mentorship of junior researchers and clinicians. She has led projects on platelet function in preterm neonates and coagulation in surgical oncology, indicating grant acquisition and team coordination capabilities. Labs and Teams: Though specific lab names are not mentioned, her work implies collaboration with clinical research teams in hematology, neonatology, oncology, and obstetrics at Aarhus University Hospital and affiliated centers.

Mohamed S. AlsammakView profile

Associate Professor

• Transfusion Medicine
• Hematopathology
• Coagulation
• +7 more

Mohamed S. Alsammak, MD, is an Associate Professor in the Department of Clinical Pathology & Laboratory Medicine at the Lewis Katz School of Medicine, Temple University. He also serves as Director of the Blood Bank/Transfusion Medicine at Temple University Hospital, where he practices in the fields of Hematologic Pathology, Blood Banking, and Transfusion Medicine. His clinical and research interests include: Transfusion medicine Therapeutic apheresis Thrombotic thrombocytopenic purpura Sickle cell disease and red cell exchange Patient blood management Hematopathology Coagulation disorders The trend in his publications reflects a strong focus on clinical applications of apheresis, transfusion support in complex medical and surgical settings, coagulation abnormalities, and laboratory-based clinical research. His work often addresses rare hematologic conditions and perioperative challenges, with increasing attention to physician well-being and transplant-related desensitization protocols. Scientific awards and distinctions include: MD with Medal of Distinction, Arabian Gulf University Competitive Scholarships for Medical School, Sponsored by The Ministry of Education in Bahrain Dr. Alsammak has been actively involved in multidisciplinary clinical research, frequently collaborating with teams in hematology, critical care, transplantation, and obstetrics. His publications suggest engagement in national surveys and case-based reporting, contributing to best practices in apheresis and transfusion medicine. While formal grant information is not available, his leadership role and scholarly output indicate active participation in clinical innovation and education. He is affiliated with key professional organizations such as the American Society for Apheresis, AABB, and the College of American Pathologists, underscoring his commitment to advancing standards in blood banking and transfusion safety.

Kathryn E. DickersonView profile

Assistant Professor

• Pediatric Hematology
• Myeloid Malignancies
• Epigenetic Regulation
• +4 more

Kathryn E. Dickerson, M.D., M.S.C.S., is an Assistant Professor in the Department of Pediatrics at UT Southwestern Medical Center, specializing in the Division of Hematology and Oncology. She holds dual appointments as a 2015 Translational Research Scholar in the UTSW Center for Translational Medicine and as an NIH KL2 scholar. Her clinical focus is pediatric hematology, emphasizing bone marrow failure disorders, cancer predisposition syndromes, and thalassemia/dyserythropoietic anemias. Her research investigates epigenetic regulation of myeloid malignancies, clonal hematopoiesis in childhood cancer survivors, and molecular mechanisms underlying acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative disorders (MPD). Education: Bachelor's in Biochemistry (Indiana University), minor in Spanish Medical degree (Indiana University School of Medicine) Masters of Science in Clinical Sciences (UT Southwestern Center for Translational Medicine) Training: Pediatric residency with research pathway (Ohio State University/Nationwide Children’s Hospital) Pediatric hematology-oncology fellowship (UT Southwestern) Dr. Dickerson’s research bridges basic science and clinical practice, leveraging CRISPR-based epigenetic editing, genomic analysis, and translational studies to understand disease mechanisms. Key projects include interrogating enhancer dysregulation in leukemia, studying metabolic reprogramming in cancers, and evaluating clonal hematopoiesis in survivors of childhood cancers. Her work has advanced understanding of EZH2’s role in AML and identified therapeutic vulnerabilities in myeloid malignancies. Awards: 2015 Translational Research Scholar (UTSW Center for Translational Medicine) NIH KL2 Career Development Award Grants/Initiatives: NIH-funded investigator-initiated study on clonal hematopoiesis Industry/consortia-sponsored trials for bone marrow failure and rare blood disorders She collaborates with the Children’s Research Institute and North American Pediatric Aplastic Anemia Consortium, contributing to clinical trials and translational initiatives. Her lab focuses on developing biomarkers for disease severity (e.g., immature platelet fraction in pediatric COVID-19) and therapeutic strategies targeting epigenetic dependencies in leukemia.

• Pharmacotherapy outcomes
• Critical care
• Trauma
• +2 more

Jeffrey F. Barletta is a Professor with tenure and Vice Chair of Pharmacy Practice at Midwestern University College of Pharmacy - Glendale Campus. With over 25 years of experience as a critical care clinician, Dr. Barletta maintains an active clinical practice at HonorHealth John C. Lincoln Medical Center in Phoenix, AZ, where he serves as a member of the trauma/surgical ICU team. His academic career includes previous positions as a clinical specialist in surgical critical care at Spectrum Health in Grand Rapids, MI and Detroit Receiving Hospital in Detroit, MI. Dr. Barletta's educational background includes: Pharm.D. from Temple University, USA (1996) B.S. from Philadelphia College of Pharmacy & Science, USA (1995) Residency in Pharmacy Practice at University of Arizona, Tucson Residency in Critical Care at University of Arizona, Tucson Dr. Barletta's research focuses on pharmacotherapy outcomes in critically ill patients , with particular emphasis on critical care and trauma. His work examines medication safety and effectiveness in high-acuity settings, especially regarding stress ulcer prophylaxis, electrolyte management, and pharmacotherapy for critically ill trauma patients. He has contributed significantly to guidelines development in critical care pharmacotherapy, particularly for stress-related gastrointestinal bleeding prevention and heat stroke management. His research bridges clinical practice and evidence-based medicine to optimize drug therapy in the ICU setting. Analysis of Dr. Barletta's recent publications reveals a strong focus on critical care pharmacotherapy, particularly stress ulcer prophylaxis, gastrointestinal bleeding prevention, and management of electrolyte disorders in critically ill patients. His work frequently appears in high-impact critical care journals and often involves multicenter collaborations. A notable trend is his leadership in developing clinical practice guidelines through professional societies like the Society of Critical Care Medicine. Dr. Barletta has received significant recognition for his contributions to the field: Fellow of the American College of Critical Care Medicine (FCCM) Fellow of the American College of Clinical Pharmacy (FCCP) As an academic leader, Dr. Barletta serves on the Council for the Society of Critical Care Medicine and has held leadership positions including past-Chair of the Clinical Pharmacy and Pharmacology Section of SCCM and past Editor of Critical Connections. He was also a past member of the American Board of Internal Medicine, Critical Care Specialty Board and an inaugural member of the Executive Committee for the Critical Care Pharmacotherapy Trials Network. His teaching activities include courses in Acute Care Management and Acute Care Patient Management. Dr. Barletta has authored more than 130 peer-reviewed manuscripts and textbook chapters and served as co-editor of "Drug-Induced Complications in the Critically Ill Patient: A Guide for Recognition and Treatment." His work demonstrates a sustained commitment to advancing critical care pharmacy practice through research, education, and professional leadership.

• Clinical Pharmacology
• Pharmacovigilance
• Thrombosis and Hemostasis
• +7 more

Jean-Michel Dogné is a full Professor at the Faculty of Medicine, University of Namur, where he leads research in clinical pharmacology and toxicology. He is affiliated with several key research centers including the Namur Medicine & Drug Innovation Center, the Namur Thrombosis and Hemostasis Center, and the Namur Nanosafety Center. His work is integral to the Namur Research Institute for Life Sciences and he actively contributes to EU-level pharmacovigilance through his role in the EMA's PRAC committee. Education: Doctor of Pharmacy, Université de Liège (2000), Thesis: Drug design and development His research focuses on anticoagulant therapy, thrombosis, drug safety, and personalized medicine , with strong emphasis on clinical applications in cancer and infectious diseases. He has led major projects such as COVILAB (on COVID-19) and studies on BCR-ABL inhibitors in leukemia. His work often involves systematic reviews, meta-analyses, and biomarker discovery, contributing to evidence-based medicine. The 15 most recent publications reflect a sustained focus on thrombosis in oncology, pharmacovigilance, anticoagulants, and pandemic research , with increasing integration of regulatory science and model-informed drug development. His work spans clinical trials, laboratory investigations, crystallography, and public health policy , demonstrating a multidisciplinary approach to pharmaceutical innovation. Scientific Awards: Prix Léo Pharma Cancer & Thrombosis (2017) Jean-Michel Dogné has supervised over 40 students and researchers, contributing significantly to training the next generation of clinical pharmacologists. He has secured numerous national and international grants, particularly in the areas of drug safety and thrombosis. His collaborative network is extensive, involving institutions across Europe and participation in EU-level regulatory bodies. He is a key member of the Clinical Pharmacology Research Group and leads major initiatives such as the MP-EMA project. His team operates within state-of-the-art facilities at the University of Namur, focusing on translational research from bench to bedside.

Lorenzo AlberioView profile

Professor

• Hematology
• Hemostasis
• Thrombosis
• +7 more

Lorenzo Alberio is a full professor at the University of Lausanne (UNIL), Faculty of Biology and Medicine, and serves as head physician at the Central Hematology Department and Laboratory of the Lausanne University Hospital (CHUV). He has held academic and clinical leadership roles since joining UNIL in 2014 and was promoted to full professor in 2024. His educational background includes a medical degree (1990) and doctorate (1993) from the University of Bern, FMH in internal medicine (1996), and specialist qualifications in hematology (1999) and analytical hematology (2002). He completed research training at the University of Oklahoma (1997–1999). Alberio's research focuses on hemostasis , platelet function , and coagulation disorders . His work includes the development of flow cytometry techniques and assays for procoagulant platelets (COATs), heparin-induced thrombocytopenia, and thrombin generation. His publications span high-impact journals and cover translational and clinical hematology, with a strong emphasis on diagnostic innovation and therapeutic applications. His recent articles reflect a consistent trend in thrombosis , platelet biology , and anticoagulation strategies , often in the context of cancer and critical care. The work bridges basic science with clinical implementation. Scientific awards include: Johann-Lukas-Schönlein Prize (2000) Multiple distinctions from the Swiss Society of Hematology Alberio is deeply committed to education and mentorship, having developed the Lausanne School of Hemostasis and actively teaching at undergraduate and postgraduate levels. He has secured significant research funding from the Swiss National Science Foundation (SNSF) and leads interdisciplinary projects. His research group operates within the Hemostasis & Platelet Research Laboratory at CHUV, part of a broader network including units in blood cancer proteostasis, targeted immunotherapies, and regenerative hematopoiesis. He maintains international collaborations with institutions in Strasbourg, Tübingen, Islamabad, Leuven, Ghent, and Maastricht. He is also President of the GTH Congress (2021, 2025), underscoring his global academic leadership.

Geert-Jan GeersingView profile

Professor

• Cardiovascular Disease Management
• Prediction Analytics
• Venous Thrombo-embolism (VTE)
• +7 more

Geert-Jan Geersing is a Full Professor at University Medical Center Utrecht, specializing in Cardiovascular Health in General Practice. He combines clinical work as a general practitioner with high-impact research focused on cardiovascular disease management, prediction analytics, and primary care innovation. Leadership: Strategic Program 'Circulatory Health' Key Research Areas: Thrombo-embolic conditions (VTE, pulmonary embolism), atrial fibrillation (AF), bleeding risk prediction, and chronic care models for frail elderly patients Notable Projects: FRAIL-AF randomized controlled trial, Horizon program for elderly cardiovascular patients His work includes developing diagnostic prediction models using individual patient data meta-analysis and improving stroke/bleeding risk stratification in anticoagulation therapy. He leads research at the intersection of clinical practice and data science. Funding & Recognition : NWO Veni/Vidi grants for thrombo-embolic condition management Future Leaders Program participant (Dutch CardioVascular Alliance) External roles include Vice-chair of the FNT (Federatie Nederlands Trombosediensten) and leadership in scientific committees.